National Defense Medical Center, Taipei, Taiwan.
Eur J Clin Invest. 2010 Feb;40(2):164-71. doi: 10.1111/j.1365-2362.2009.02239.x. Epub 2009 Dec 21.
The aim was to examine whether the inhibition of selective cyclooxygenase (COX) 2 activation could suppress the development of inflammatory reaction in visceral and subcutaneous abdominal fats of high-fat-induced obese rats.
The rats were fed separately regular diet (CONT), high-fat diet ad libitum or energy-restrictedly (HFr) for 12 weeks. Rats fed high-fat diet ad libitum were further divided into those co-treated with vehicle (HFa), a selective COX2 inhibitor-celecoxib (HFa-Cel) or nimesulide (HFa-Nim). Oral glucose tolerance test (OGTT) was performed at the end of weeks 4, 8, 12. Another set of rats with similar grouping was divided into those with a 4-, 8- or 12-week intervention for tissue sampling.
Body and epididymal fat weights were increased similarly in HFa, HFa-Cel and HFa-Nim. Time-dependent increases in plasma insulin, triglyceride, impaired OGTT shown in HFa were significantly reversed in HFa-Cel and HFa-Nim. The obese-linked increases in gene expressions of COX-2, monocyte chemoattractant protein-1 (MCP-1) and tumour necrosis factor-alpha (TNF-alpha) in epididymal and subcutaneous fats (especially in the former) were significantly suppressed in HFa-Cel and HFa-Nim. The protein contents of MCP-1 and TNF-alpha in epididymal fats were changed consistently with their gene expressions. Plasma MCP-1 was increased time-dependently in HFa and suppressed in HFa-Cel and HFa-Nim. The increased CD68 positive cells showed in both epididymal and subcutaneous fats of HFa were significantly attenuated in HFa-Cel and HFa-Nim.
Our findings suggest that COX2 activation is crucially involved in the development of inflammatory response in adipose tissues of high-fat-induced obese rats.
本研究旨在探讨选择性环氧化酶(COX)2 抑制剂是否能抑制高脂诱导肥胖大鼠内脏和皮下腹部脂肪中炎症反应的发展。
将大鼠分别给予普通饮食(CONT)、自由进食高脂饮食(HFr)或能量限制高脂饮食(HFr)12 周。自由进食高脂饮食的大鼠进一步分为vehicle(HFa)、选择性 COX2 抑制剂塞来昔布(HFa-Cel)或尼美舒利(HFa-Nim)联合治疗组。在第 4、8、12 周末进行口服葡萄糖耐量试验(OGTT)。另一组具有相似分组的大鼠分为 4、8 或 12 周干预组进行组织取样。
HFa、HFa-Cel 和 HFa-Nim 组大鼠体重和附睾脂肪重量均增加。HFa 组大鼠血浆胰岛素、甘油三酯水平随时间升高,OGTT 受损,HFa-Cel 和 HFa-Nim 组明显逆转。HFa-Cel 和 HFa-Nim 组大鼠附睾和皮下脂肪组织中肥胖相关的 COX-2、单核细胞趋化蛋白-1(MCP-1)和肿瘤坏死因子-α(TNF-α)基因表达增加均受到显著抑制(尤其在前者)。附睾脂肪组织中 MCP-1 和 TNF-α蛋白含量与基因表达一致变化。HFa 组大鼠血浆 MCP-1 随时间升高,HFa-Cel 和 HFa-Nim 组抑制。HFa 组大鼠附睾和皮下脂肪组织中 CD68 阳性细胞增加,HFa-Cel 和 HFa-Nim 组明显减少。
本研究结果表明 COX2 激活在高脂诱导肥胖大鼠脂肪组织炎症反应的发展中起关键作用。